Group A (n=24) | Group B (n=17) | |
---|---|---|
Mean age (years) | 65.2±13.6 | 58.6±12.1 |
Treatment with | ||
Biologic drugs | 13 | 0 |
DMARDs | 16 | 0 |
Prednisone | 17 | 0 |
Impairment of well-being (rated on a scale of 1–10) | 7.5±3.4 | 8.4±2.4 |
Max. number of vomiting episodes/day | 3.6±3.1 | 3.9±4.5 |
Max. number of diarrhoea episodes/day | 4.8±4.5 | 4.3±3.9 |
Colics and abdominal pain | 14 (58%) | 14 (82%) |
Duration of symptoms (days) | 2.6±2.0 | 2.2±1.4 |
Persistent norovirus detection after 7 weeks | 0/24 | 0/17 |